1. Home
  2. Africa

UN tardy about approving cheap AIDS drugs - MSF

The international medical NGO, Medecins Sans Frontieres (MSF), has accused the World Health Organisation (WHO) of being tardy in its approval of cheap drugs to combat HIV/AIDS in developing countries.

MSF said millions of people lacked access to affordable treatment because WHO's drug inspection programme was "understaffed and hampered by politics".

Reuters quoted Rowan Gillies, the head of MSF's international council, as saying: "This is restricting patients' access to essential medicines in many of the places we work in, particularly in countries that have limited capacity to assess the quality of medicines themselves."

The UN health agency has responded by saying that delays were less the result of a lack of resources than a measure of the painstaking efforts undertaken to ensure that the medicines it approved met its quality standards.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join